"disguised" (the word is mine) in white coats, in the interests of acceptability, when let loose in hospitals.
Davies and Hayes have interesting papers on the intricate relation between nurses, doctors and medical students and how they handle people with cancer, but the discussion they provoked was even more revealing. Hayes made a brief comment, which one would have liked to see developed at greater length, because it gets to the root of how medical students are to be taught something of the behavioural sciences (of marginal interest to those becoming doctors). Pursuing the comment on white coats, he said, "...the only people to whom they listen effectively are those who wear long white coats. Therefore, if the physician does not teach them the behavioural sciences, they will not perceive it as having much value or being beneficial ".
Klonglan and Bohlen have one of the most stimulating chapters on how the public adopts innovations in cancer control. The discussion that followed this section ranged widely, and several participants slapped at mosquitoes that had been irritating them from earlier seasons. Goldstein, Evans and Mendelsohn, with varying degrees of acerbity, reacted to early comments by James about methods of getting the public to do the things the professionals think best for them.
The discussion after the section on mass media in cancer control was also, fortunately, allowed to spill over into all sorts of other topics and to become splendidly rough. One wishes it could have gone on longer. Here, the still-yawning gap between researchers in the social sciences and those who hope to make something of the findings (doctors, lay educators and so on) is revealed most clearly. Leventhal, goaded by comments about why researchers " don't do something ", spoke feelingly of meetings of many health agencies where he has put his case. " You give example after example, and it just doesn't get through ", followed by the revealing comment that " those of us who do research . . . don't have the time to translate our findings ". There are many comments that would illuminate the regrettable gap in what each side expects of the other, but the point need not be laboured. Hochbaum's final comment on this point in the discussion could only be diluted by any attempt at paraphrase; " It is very strange and rather ironic that we are here to tell our colleagues in the health professions how to communicate effectively with, and influence effectively, the lay population. Yet we behavioral scientists constantly bemoan the fact that we are unable to influence the health professions, to communicate with them, and persuade them to change their behavior. Something about it is not quite right."
If any reader is looking for some consensus of views about how the social sciences can help in cancer control, he will be disappointed. Some things, too, depending on his own convictions and training, will make him irritated and cross. Yet few conference proceedings have the power to do even that. This may be a strange mixture of contributions, of variable quality, but it has stirred this reviewer, as it will other readers, to lots of notes in the margins, to mark something he wishes he might have said, and even more expletive exclamation marks. It does not take either us, in the behavioural sciences, or doctors and others involved in preventing and dealing with cancer, much further. But there are enough ideas floating around in it for everyone to pick something out and, echoing Leventhal's plea, to stop and make time to think about it.
J This is a valuable practical handbook for all concerned with the diagnosis and management of malignant disease in children. The constant theme is that a real possibility of cure now exists in many types of childhood malignancy, but that realization of this requires an unprecedented degree of interdisciplinary co-operation between surgeon, radiotherapist, chemotherapist, diagnostic radiologist, pathologist and others. The four editors, from the U.K., France, West Germany and the Netherlands respectively, have gathered an additional 41 contributors, mainly from Europe and North America, who include many of the " household names " from the various disciplines of Paediatric Oncology listed above. Since many of these workers already co-operate within Soc. Int. One. Ped. trials there is greater uniformity of approach than might otherwise be the case.
Following 9 chapters devoted to general topics such as pathology, surgery, radiotherapy, chemotherapy and the problems of infections, there are 15 specialized chapters each dealing with a particular group of tumours, primarily subdivided on a regional or system basis. Used as a clinical handbook this section will answer most problems concerned with initial diagnostic work-up and staging and treatment planning likely to be encountered in paediatric practice. The enthusiasm and expertise of the individual contributors comes out well and makes the text eminently readable. Reference to their personal clinical series, and to the ongoing clinical trials of co-operative groups, gives a realistic prognosis for each staging of the common paediatric tumours; although it is also clearly implied that the whole subject is in a state of active evolution.
Radiotherapy is given much more prominence and described in greater detail than is found in recent books on paediatric or medical oncology, and this is a welcome addition for those of us who are not fully versed in this aspect. In particular, the problems of integrating radiotherapy with the surgical and chemotherapeutic components of combined modality schedules for tumours such as Wilms', Ewing's and rhabdomyosarcoma are clearly detailed. Immunotherapy, by contrast, receives less prominence than one is accustomed to, being mentioned only in relation to leukaemia, Burkitt's tumour and malignant melanoma. This limited emphasis is probably justified in the present state of knowledge, especially in a practical handbook such as this.
In summary, I think that this book should be available in all units undertaking treatment of childhood tumours. Published in 1975, it will unfortunately soon be a little out-of-date with regard to some aspects of chemotherapy. For instance, only preliminary mention of high-dose methotrexate and adriamycin in osteogenic sarcoma is included (the relevant definitive articles appearing only in the last months of 1974 The concept that the immune response constitutes a principal defence mechanism against cancer has had far-reaching influence on oncological research in the last 15 years. The term " immune surveillance " owes its origin to Sir McFarlane Burnet who based his development of the concept on the earlier formulation of L. Thomas. In essence, the theory postulates that incipient cancer cells are eliminated by host immune reactions mediated by effector cells primed to recognize their targets by virtue of the antigenic disparity between the normal and malignant tissues of the host. The neoantigenicity of many experimental neoplasms (and of a few human malignant diseases too) is now well established, adding to the simplicity of the hypothesis a degree of heuristic appeal. However, a theory is not a dogma, and the problem of the immunosurveillance hypothesis is that it has been in danger of becoming accepted as a fact.
To redress the balance G. Moller has elicited 5 contributions from 8 authors on aspects of experimental oncology which impinge directly on, or have implications for, the immunosurveillance hypothesis. This is the second volume of Transplantation Reviews to be devoted to the topic (cf. Immunological Surveillance against Neoplasia, Trans. Rev., 7, 1971) . While the earlier volume showed unanimity about the general plausibility of the theory, the present volume is largely critical. The views of the Editor who (with Erna Moller) sets the tone in the " Foreword " have recently been made widely known. He argues, with great cogency, that the previous need to find a normal biological function for T cells is no longer pressing (as it was when Thomas first propounded his theory), since it is now well-established that a main function of these lymphocytes is to defend the host against otherwise lethal microbial infections.
For the Mollers, the absence of spontaneous tumours in nude mice, in spite of the complete lack of a functional T-cell system, is the strongest single argument against the concept. In this respect their views accord with those of Rygaard and Povlsen (" The
